Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Constrained Functional Impact in <em>Cdkl5</em> KO Mice
Manuela Loi(University of Bologna), Elisabetta Ciani(University of Bologna)
Cited by 0
Related Papers
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder
|Neural Plasticity|2018|62
Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB Agonist
|Frontiers in Cellular Neuroscience|2019|47
Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder
|Research Square|2024|0
Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder
|Journal of Neurodevelopmental Disorders|2024|0
Endocannabinoid Enhancement via MAGL Inhibition in CDKL5 Deficiency: Selective Cellular Benefits and Domain-Specific Functional Effects in Adult Cdkl5 KO Mice
|International Journal of Molecular Sciences|2026|0